Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies

Megan M. Harper, Joseph Kim, Prakash K. Pandalai

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

Peritoneal carcinomatosis (PC) is a poor prognostic factor for all malignancies. This extent of metastatic disease progression remains difficult to treat with systemic therapies due to poor peritoneal vascularization resulting in limited drug delivery and penetration into tissues. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are surgical interventions that directly target peritoneal tumors and have improved outcomes for PC resulting from appendiceal and colorectal cancer (CRC). Despite these radical therapies, long-term survival remains infrequent, and recurrence is common. The reasons for these outcomes are multifactorial and signal the need for the continued development of novel therapeutics, techniques, and approaches to improve outcomes for these patients. Here, we review landmark historical studies that serve as the foundation for current recommendations, recent discoveries, clinical trials, active research, and areas of future interest in CRS/HIPEC to treat PC originating from appendiceal and colorectal malignancies.

Original languageEnglish
Article number2840
JournalJournal of Clinical Medicine
Volume11
Issue number10
DOIs
StatePublished - May 1 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • appendiceal cancer
  • colorectal cancer
  • cytoreductive surgery (CRS)
  • hyperthermic intraperitoneal chemotherapy (HIPEC)
  • peritoneal carcinomatosis
  • peritoneal surface malignancies (PSM)

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies'. Together they form a unique fingerprint.

Cite this